Megan M Marron1, Jatinder Singh2, Robert M Boudreau1, Kaare Christensen3, Stephanie Cosentino4, Mary F Feitosa5, Ryan L Minster2, Thomas Perls6, Nicole Schupf4, Paola Sebastiani7, Svetlana Ukraintseva8, Mary K Wojczynski5, Anne B Newman1,9. 1. Department of Epidemiology. 2. Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 3. Department of Public Health, The Danish Aging Research Center, University of Southern Denmark, Odense, Denmark. 4. Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University Medical Center, New York, New York. 5. Division of Statistical Genomics, Department of Genetics, Washington University School of Medicine, St. Louis, Missouri. 6. Department of Medicine, Geriatrics Section, Boston Medical Center, Boston University School of Medicine. 7. Department of Biostatistics, Boston University, Boston, Massachusetts. 8. Center for Population Health and Aging, Department of Sociology, Duke University, Durham, North Carolina. 9. Departments of Medicine and Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Abstract
BACKGROUND: Hypertension tends to run in families and has both genetic and environmental determinants. We assessed the hypothesis that a novel healthy blood pressure (BP) phenotype is also familial and sought to identify its associated factors. METHODS: We developed a healthy BP phenotype in the Long Life Family Study, a cohort of two-generation families selected for longevity. Participants from the offspring generation (n = 2211, ages 32-88) were classified as having healthy BP if their age-adjusted and sex-adjusted SBP z-score was between -1.5 and -0.5. Offspring on antihypertensive medications were classified as not having healthy BP. Families with at least two offspring (n = 419 families) were defined as meeting the healthy BP phenotype if at least two and at least 50% of their offspring had healthy BP. RESULTS: Among 2211 offspring, 476 (21.5%) met the healthy BP phenotype. When examining the 419 families, only 44 (10.5%) families met the criteria for the healthy BP phenotype. Both offspring and probands from families with healthy BP performed better on neuropsychological tests that place demands on complex attention and executive function when compared with offspring and probands from remaining families. Among families with the healthy BP phenotype compared with families without, a higher proportion of offspring met the American Heart Association definition of ideal cardiovascular health (10.8 versus 3.8%, respectively; driven by BP, smoking status, and BMI components). CONCLUSION: In this cohort of familial longevity, few families had a novel healthy BP phenotype in multiple members. Families with this healthy BP phenotype may represent a specific pathway to familial longevity.
BACKGROUND:Hypertension tends to run in families and has both genetic and environmental determinants. We assessed the hypothesis that a novel healthy blood pressure (BP) phenotype is also familial and sought to identify its associated factors. METHODS: We developed a healthy BP phenotype in the Long Life Family Study, a cohort of two-generation families selected for longevity. Participants from the offspring generation (n = 2211, ages 32-88) were classified as having healthy BP if their age-adjusted and sex-adjusted SBP z-score was between -1.5 and -0.5. Offspring on antihypertensive medications were classified as not having healthy BP. Families with at least two offspring (n = 419 families) were defined as meeting the healthy BP phenotype if at least two and at least 50% of their offspring had healthy BP. RESULTS: Among 2211 offspring, 476 (21.5%) met the healthy BP phenotype. When examining the 419 families, only 44 (10.5%) families met the criteria for the healthy BP phenotype. Both offspring and probands from families with healthy BP performed better on neuropsychological tests that place demands on complex attention and executive function when compared with offspring and probands from remaining families. Among families with the healthy BP phenotype compared with families without, a higher proportion of offspring met the American Heart Association definition of ideal cardiovascular health (10.8 versus 3.8%, respectively; driven by BP, smoking status, and BMI components). CONCLUSION: In this cohort of familial longevity, few families had a novel healthy BP phenotype in multiple members. Families with this healthy BP phenotype may represent a specific pathway to familial longevity.
Authors: Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He Journal: Lancet Date: 2005 Jan 15-21 Impact factor: 79.321
Authors: Vanessa Xanthakis; Danielle M Enserro; Joanne M Murabito; Joseph F Polak; Kai C Wollert; James L Januzzi; Thomas J Wang; Geoffrey Tofler; Ramachandran S Vasan Journal: Circulation Date: 2014-10-01 Impact factor: 29.690
Authors: B M Psaty; C D Furberg; L H Kuller; M Cushman; P J Savage; D Levine; D H O'Leary; R N Bryan; M Anderson; T Lumley Journal: Arch Intern Med Date: 2001-05-14
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark Journal: Neurology Date: 1989-09 Impact factor: 9.910
Authors: Joseph T Knapper; Nima Ghasemzadeh; Mohamed Khayata; Sulay P Patel; Arshed A Quyyumi; Shanthi Mendis; George A Mensah; Kathryn Taubert; Laurence S Sperling Journal: J Am Coll Cardiol Date: 2015-08-25 Impact factor: 24.094
Authors: Megan M Marron; Mary K Wojczynski; Ryan L Minster; Robert M Boudreau; Paola Sebastiani; Stephanie Cosentino; Bharat Thyagarajan; Svetlana V Ukraintseva; Nicole Schupf; Kaare Christensen; Mary Feitosa; Thomas Perls; Joseph M Zmuda; Anne B Newman Journal: Geroscience Date: 2019-07-22 Impact factor: 7.713
Authors: Megan M Marron; Iva Miljkovic; Robert M Boudreau; Kaare Christensen; Mary F Feitosa; Joseph H Lee; Paola Sebastiani; Bharat Thyagarajan; Mary K Wojczynski; Joseph M Zmuda; Anne B Newman Journal: Metabolism Date: 2019-01-30 Impact factor: 8.694
Authors: Mary K Wojczynski; Shiow Jiuan Lin; Paola Sebastiani; Thomas T Perls; Joseph Lee; Alexander Kulminski; Anne Newman; Joe M Zmuda; Kaare Christensen; Michael A Province Journal: J Gerontol A Biol Sci Med Sci Date: 2022-04-01 Impact factor: 6.053